Mycobacterium Avium Paratuberculosis (MAP)
Mycobacterium avium subspecies paratuberculosis (MAP) was first identified in 1895 by Heinrich A. Johne and L. Frothingham, who found the organism in cattle with chronic intestinal disease—what is now known as Johne’s disease. Wikipedia
1. Clinical Johne’s disease causes major performance losses
A retrospective Irish dairy‑herd study found that cows with clinical Johne’s disease produced 1,259 kg less milk per lactation and were culled earlier with €516 lower cull value compared to matched controls. This reflects severe productivity decline, which is strongly associated with early removal.
2. Johne’s drives “excessive culling”
Johne’s disease is explicitly described as causing excessive culling, suboptimal milk production, decreased fertility, and death loss.
These are the primary drivers shortening productive lifespan.
3. Clinical animals often survive only weeks once symptomatic
USDA APHIS notes that once clinical diarrhea appears, affected cattle “will not live very long—perhaps a few weeks at most.” This means clinical cows lose nearly 100% of their remaining productive lifespan at the point of clinical onset.
MAP-derived Lifetime Loss Estimate for Dairy Cows
A normal dairy cow is typically productive for ~3–4 years after first calving. Johne’s disease affects lifespan in two distinct ways:
A. Subclinical infection (most infected cows)
Reduced milk yield
Higher culling for infertility
Higher replacement rate
Earlier removal, but not catastrophic
Estimated ~15–25% reduction in productive lifespan (≈ 6–12 months lost out of a 3–4 year productive window)
B. Clinical Johne’s disease (small subset that progresses)
Rapid decline
Removal within weeks
Essentially complete loss of remaining productive life
Estimated ~80–100% reduction in remaining productive lifespan (once clinical signs appear)
Conclusion - an estimated 20-30% productive lifespan loss
Across all infected animals (weighted by the fact that most are subclinical):
Johne’s disease reduces a dairy cow’s productive lifespan by approximately 20–30% on average, with clinical cases losing nearly all remaining productive life.